MedTrace Logo

Post-COVID-19 Chronic Fatigue Syndrome

NCT05642923 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 528

Last updated 2025-03-10

No results posted yet for this study

Summary

Fatigue is recognized as one of the most commonly presented long-term complaints in individuals previously infected with SARS-CoV-2.

Conditions

  • Post-COVID-19 Syndrome
  • Post-COVID Syndrome

Interventions

DRUG

Synthetic Vitamin B1

Synthetic Vitamin B1 400 mg per day

Sponsors & Collaborators

  • As-Salam Center, Maadi, Cairo, Egypt

    collaborator UNKNOWN

  • ClinAmygate

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-08
Primary Completion
2024-06-01
Completion
2025-03-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05642923 on ClinicalTrials.gov